T

Theriva Biologics
D

TOVX

0.46120
USD
-0.02
(-4.89%)
مغلق
حجم التداول
12,080
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
4,426,575
الأخبار المقالات

العنوان: Theriva Biologics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.